Stock listing
NYSE:TDOC Teladoc Health, Inc. Stock
Home listing (NYSE) of Teladoc Health, Inc.
Follow Teladoc Health, Inc. into a list and get an email when it puts out news.
Share price · NYSE:TDOC
$7.45 USD -0.61 (-7.6%)
Close on Nov 20, 2026
- Day range
- $7.40 – $7.88 USDNov 20, 2026
- Volume
- 4.71M sharesNov 20, 2026
- Market cap
- $1.36B USDAt the close on Nov 20, 2026 · price × 182.3M shares outstanding
- 52-week range
- $4.40 – $9.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $29.83M USDMedian day 3.47M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:TDOC · Home | $7.45 USD | -0.61 (-7.6%) | 4,706,934 | $7.68 | $7.875 | $7.40 | $8.06 | Close on Nov 20, 2026 |
| Frankfurt:4LL | €6.966 EUR | -0.314 (-4.3%) | — | €6.966 | €6.966 | €6.966 | €7.28 | Close on Nov 20, 2026 |
| LSE:0LDR | $7.51 USD | -0.31 (-4.0%) | 91,598 | $7.82 | $7.89 | $7.49 | $7.82 | Close on Nov 20, 2026 |
| B3:T2DH34 | 49.24 BRL | -1.01 (-2.0%) | — | 49.24 | 49.24 | 49.24 | 50.25 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:TDOC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.45 | -0.61 | -7.6% | $7.68 | $7.875 | $7.40 | 4,706,934 | |
| $8.06 | -0.43 | -5.1% | $8.40 | $8.71 | $8.045 | 3,963,643 | |
| $8.49 | -0.21 | -2.4% | $8.56 | $8.623 | $8.32 | 4,762,370 | |
| $8.70 | -0.10 | -1.1% | $8.71 | $8.85 | $8.565 | 2,924,581 | |
| $8.80 | +0.11 | +1.3% | $8.68 | $8.91 | $8.645 | 3,134,268 | |
| $8.69 | -0.25 | -2.8% | $8.82 | $8.94 | $8.64 | 3,096,814 | |
| $8.94 | 0.00 | 0.0% | $8.96 | $9.125 | $8.83 | 3,474,910 | |
| $8.94 | -0.04 | -0.4% | $8.85 | $9.009 | $8.415 | 4,853,633 | |
| $8.98 | +0.21 | +2.4% | $8.94 | $9.17 | $8.86 | 4,029,994 | |
| $8.77 | -0.64 | -6.8% | $9.20 | $9.45 | $8.75 | 5,725,041 | |
| $9.41 | -0.29 | -3.0% | $9.66 | $9.79 | $8.99 | 10,399,271 | |
| $9.70 | +0.81 | +9.1% | $8.89 | $9.75 | $8.83 | 7,277,407 | |
| $8.89 | +0.26 | +3.0% | $8.58 | $9.055 | $8.56 | 6,105,470 | |
| $8.63 | +0.12 | +1.4% | $8.56 | $8.76 | $8.13 | 6,062,216 | |
| $8.51 | -0.22 | -2.5% | $8.81 | $8.99 | $8.12 | 8,158,500 | |
| $8.73 | +1.85 | +26.9% | $7.92 | $8.99 | $7.90 | 20,129,200 | |
| $6.88 | +0.43 | +6.7% | $6.41 | $6.92 | $6.40 | 8,643,100 | |
| $6.45 | +0.21 | +3.4% | $6.25 | $6.46 | $6.18 | 3,975,700 | |
| $6.24 | -0.10 | -1.6% | $6.32 | $6.38 | $6.14 | 3,396,500 | |
| $6.34 | +0.02 | +0.3% | $6.275 | $6.39 | $6.20 | 2,476,700 | |
| $6.32 | +0.02 | +0.3% | $6.28 | $6.405 | $6.28 | 2,816,900 | |
| $6.30 | +0.09 | +1.4% | $6.16 | $6.365 | $6.14 | 2,618,900 | |
| $6.21 | +0.48 | +8.4% | $5.79 | $6.27 | $5.76 | 4,782,500 | |
| $5.73 | +0.06 | +1.1% | $5.61 | $5.745 | $5.57 | 2,679,800 | |
| $5.67 | -0.30 | -5.0% | $6.02 | $6.025 | $5.64 | 2,936,900 | |
| $5.97 | +0.16 | +2.8% | $5.85 | $5.98 | $5.76 | 2,933,000 | |
| $5.81 | -0.19 | -3.2% | $5.81 | $5.96 | $5.71 | 3,512,700 | |
| $6.00 | +0.08 | +1.4% | $5.93 | $6.175 | $5.88 | 4,278,900 | |
| $5.92 | +0.15 | +2.6% | $5.82 | $5.98 | $5.73 | 3,251,100 | |
| $5.77 | +0.23 | +4.2% | $5.52 | $5.80 | $5.485 | 4,179,700 | |
| $5.54 | -0.02 | -0.4% | $5.50 | $5.545 | $5.42 | 4,668,500 | |
| $5.56 | -0.21 | -3.6% | $5.76 | $5.761 | $5.53 | 3,623,000 | |
| $5.77 | -0.02 | -0.3% | $5.82 | $5.85 | $5.685 | 3,724,500 | |
| $5.79 | +0.27 | +4.9% | $5.50 | $5.81 | $5.48 | 4,469,600 | |
| $5.52 | -0.15 | -2.6% | $5.74 | $5.745 | $5.48 | 4,891,500 | |
| $5.67 | -0.13 | -2.2% | $5.87 | $5.93 | $5.65 | 3,421,600 | |
| $5.80 | +0.05 | +0.9% | $5.81 | $5.92 | $5.75 | 3,407,500 | |
| $5.75 | -0.14 | -2.4% | $5.86 | $5.90 | $5.71 | 3,740,900 | |
| $5.89 | -0.20 | -3.3% | $6.05 | $6.07 | $5.85 | 4,148,700 | |
| $6.09 | -0.05 | -0.8% | $6.10 | $6.18 | $5.97 | 3,022,500 | |
| $6.14 | +0.01 | +0.2% | $6.19 | $6.235 | $6.07 | 3,022,600 | |
| $6.13 | -0.22 | -3.5% | $6.28 | $6.32 | $6.115 | 2,966,500 | |
| $6.35 | +0.08 | +1.3% | $6.345 | $6.47 | $6.215 | 2,988,200 | |
| $6.27 | -0.03 | -0.5% | $6.365 | $6.38 | $6.22 | 2,995,000 | |
| $6.30 | +0.02 | +0.3% | $6.31 | $6.34 | $6.185 | 5,496,200 | |
| $6.28 | -0.15 | -2.3% | $6.52 | $6.55 | $6.28 | 2,536,400 | |
| $6.43 | -0.15 | -2.3% | $6.55 | $6.56 | $6.37 | 2,752,100 | |
| $6.58 | +0.08 | +1.2% | $6.45 | $6.73 | $6.42 | 3,551,800 | |
| $6.50 | +0.34 | +5.5% | $6.25 | $6.57 | $6.21 | 3,469,500 | |
| $6.16 | +0.07 | +1.1% | $6.09 | $6.195 | $6.04 | 2,565,300 | |
| $6.09 | -0.01 | -0.2% | $6.08 | $6.205 | $6.045 | 2,519,000 | |
| $6.10 | -0.16 | -2.6% | $6.28 | $6.29 | $6.00 | 3,780,800 | |
| $6.26 | -0.02 | -0.3% | $6.17 | $6.38 | $6.15 | 3,778,400 | |
| $6.28 | -0.19 | -2.9% | $6.34 | $6.42 | $6.25 | 2,954,300 | |
| $6.47 | +0.01 | +0.2% | $6.51 | $6.61 | $6.39 | 2,566,500 | |
| $6.46 | +0.20 | +3.2% | $6.22 | $6.585 | $6.22 | 3,898,000 | |
| $6.26 | -0.08 | -1.3% | $6.25 | $6.39 | $6.23 | 3,448,300 | |
| $6.34 | -0.16 | -2.5% | $6.37 | $6.45 | $6.17 | 5,132,500 | |
| $6.50 | +0.14 | +2.2% | $6.40 | $6.59 | $6.395 | 3,669,000 | |
| $6.36 | +0.03 | +0.5% | $6.39 | $6.46 | $6.32 | 2,478,800 | |
| $6.33 | +0.14 | +2.3% | $6.14 | $6.38 | $6.13 | 3,086,700 | |
| $6.19 | -0.01 | -0.2% | $6.23 | $6.265 | $6.12 | 3,265,200 | |
| $6.20 | -0.19 | -3.0% | $6.37 | $6.40 | $6.17 | 3,173,900 | |
| $6.39 | -0.10 | -1.5% | $6.50 | $6.535 | $6.35 | 3,468,300 | |
| $6.49 | -0.17 | -2.6% | $6.63 | $6.82 | $6.47 | 3,023,000 |
- Ticker
- NYSE:TDOC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications
Latest earnings call · Oct 28, 2026
Teladoc Health (NYSE:TDOC) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 28, 2026
Q3 2026 Earnings Presentation
Earnings · 14 slides
Latest news
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications
Nov 17, 2026
Closed $8.49 (-2.4%) on Nov 17, 2026
Teladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province
Nov 12, 2026
Closed $8.69 (-2.8%) on Nov 12, 2026
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Nov 3, 2026
Closed $9.70 (+9.1%) on Nov 4, 2026
3Q26 Earnings Release
Oct 28, 2026
Closed $8.73 (+26.9%) on Oct 29, 2026
Teladoc Health Reports Third Quarter 2026 Results
Oct 28, 2026
Closed $8.73 (+26.9%) on Oct 29, 2026
Teladoc Health to Announce Third Quarter 2026 Financial Results
Oct 14, 2026
Closed $5.97 (+2.8%) on Oct 15, 2026
Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery
Oct 7, 2026
Closed $5.56 (-3.6%) on Oct 7, 2026
Teladoc Health Announces Chief Legal Officer Transition
Sep 25, 2026
Closed $6.09 (-0.8%) on Sep 25, 2026
Teladoc Health Appoints Michael Grasher as Chief Financial Officer
Aug 31, 2026
Closed $6.34 (-2.5%) on Aug 31, 2026
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
Aug 3, 2026
Closed $6.71 (+0.4%) on Aug 4, 2026
Teladoc Health, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 23 in the last 12 months · 49 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Oct 28, 2026
- Decks
- 51 decks · latest Oct 28, 2026
Where Teladoc Health, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:TDOC · Home listing · This page | NYSE | United States | USD |
| gettex:4LL | gettex | Germany | EUR |
| Tradegate:4LL | Tradegate | Germany | EUR |
| LS Exchange:A14VPK | LS Exchange | Germany | EUR |
| Frankfurt:4LL | Frankfurt | Germany | EUR |
| BMV:TDOC | BMV | Mexico | MXN |
| LSE:0LDR | LSE | United Kingdom | USD |
| B3:T2DH34 | B3 | Brazil | BRL |
| Lang & Schwarz:A14VPK | Lang & Schwarz | Germany | EUR |
| Stuttgart:4LL | Stuttgart | Germany | EUR |
| BOATS:TDOC | BOATS | United States | USD |
| BIVA:TDOC | BIVA | Mexico | MXN |
| BX Swiss:4LL | BX Swiss | Switzerland | CHF |
| Dusseldorf:4LL | Dusseldorf | Germany | EUR |
| Hamburg:4LL | Hamburg | Germany | EUR |
| Munich:4LL | Munich | Germany | EUR |
Valuation
EV/sales 0.2× against a median of 1.7×: the lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $508.2M USD
- P/E
- Loss
- EV/sales
- 0.2×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.1×
- Gross margin
- Not reported
- Operating margin
- −6.6%
- Net margin
- −6.3%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.13
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health, Inc. · NYSE:TDOC | US$1.36B | US$508.2M | n/a | 0.2× | n/a | 1.1× | −6.3% | 0.0× | 1.13 |
| Astrana Health Inc. · NASDAQ:ASTH | US$1.43B | US$1.96B | 27.0× | 0.5× | 10.7× | 1.7× | 1.4% | 1.1× | 0.66 |
| U.S. Physical Therapy, Inc. · NYSE:USPH | US$1.43B | US$1.64B | 47.5× | 2.0× | 16.6× | 3.3× | 3.6% | 0.6× | 0.24 |
| Ambea AB · OMXSTO:AMBEA | US$1.41B | US$1.71B | 17.1× | 1.0× | 5.5× | 3.1× | 4.9% | 0.7× | n/a |
| Rainbow Childrens Medicare Limited · NSE:RAINBOW | US$1.38B | US$1.44B | 43.6× | 6.9× | 22.4× | 7.4× | 15.2% | 0.6× | n/a |
| Xi'an International Medical Investment Co. Ltd. Class A · SZSE:000516 | US$1.37B | US$1.60B | n/a | 2.6× | n/a | 2.8× | −2.2% | 0.6× | n/a |
| Lumexa Imaging Holdings, Inc. · NASDAQ:LMRI | US$1.37B | US$2.12B | n/a | 2.0× | 19.3× | 2.2× | −1.6% | 1.3× | 1.25 |
| Ping An Healthcare and Technology Company Limited · HKEX:1833 | US$1.31B | US$235.9M | 23.1× | 0.3× | 9.1× | 0.9× | 6.9% | 0.0× | n/a |
| Spire Healthcare Group PLC · LSE:SPI | US$1.31B | US$2.98B | 60.9× | 1.4× | 9.4× | 1.4× | 1.0% | 1.8× | n/a |
| Sanbo Hospital Management Group Limited Class A · SZSE:301293 | US$1.30B | US$1.30B | 127× | 4.5× | n/a | 3.6× | 3.5% | 0.2× | n/a |
| Clariane SE · EURONEXT:CLARI | US$1.28B | US$8.88B | 731× | 1.5× | 8.0× | 0.3× | 0.0% | 2.3× | n/a |
| Median of the others | US$1.37B | US$1.67B | 45.6× | 1.7× | 10.0× | 2.5× | 2.5% | 0.6× | 0.66 |
Forecasts
5 strong buy · 1 buy · 16 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 8.81 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.71 · 5 analysts
- Revenue, year to Dec 2026
- 2.42B · 20 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Chuck Divita | Chief Executive Officer |
| Michael Grasher | Chief Financial Officer |
| Carlos Nueno | President, Global Health Systems |
| Fernando Madeira | President, BetterHelp |
| Kelly Bliss | President, U.S. Group Health |
| Jonathan Dorfman | Chief Legal Officer |
| Dave Ross | Chief Technology Officer |
| Ethan Berke | Chief Medical Officer |
| Laura Whipple | Chief Communications & Brand Officer |
| Teri Condon | Chief of Staff to the CEO |
Board
| Director | Role |
|---|---|
| Mark V. Anquillare | Director |
| Michael Smith | Director |
| Susan Salka | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Teladoc Health (NYSE:TDOC) Q3 2026 Earnings Call | Wed, Oct 28, 2026 · 5:00 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 5:00 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 5:00 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q4 2025 Earnings Call | Wed, Feb 25, 2026 · 5:00 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q3 2025 Earnings Call | Wed, Oct 29, 2025 · 5:00 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q2 2025 Earnings Call | Tue, Jul 29, 2025 · 4:30 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q1 2025 Earnings Call | Wed, Apr 30, 2025 · 4:30 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q4 2024 Earnings Call | Wed, Feb 26, 2025 · 4:30 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 4:30 PM ET | Replay |
| Teladoc Health (NYSE:TDOC) Q2 2024 Earnings Call | Wed, Jul 31, 2024 · 4:30 PM ET | Replay |
All 31 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · After close | +26.9% |
| Q2 2026 | Jul 29, 2026 · After close | −28.3% |
| Q1 2026 | Apr 29, 2026 · After close | +1.9% |
| Q4 2025 | Feb 24, 2026 | +2.0% |
| Q3 2025 | Oct 29, 2025 · After close | +6.2% |
| Q2 2025 | Jul 29, 2025 · After close | −1.7% |
| Q1 2025 | Apr 30, 2025 · After close | −2.8% |
| Q4 2024 | Feb 18, 2025 · Before open | −8.5% |
| Q3 2024 | Oct 30, 2024 · After close | +1.6% |
| Q2 2024 | Jul 31, 2024 · After close | −8.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 25, 2024 · After close | −2.4% |
| Q4 2023 | Feb 20, 2024 · After close | −23.7% |
| Q3 2023 | Oct 24, 2023 · After close | −3.9% |
| Q2 2023 | Jul 25, 2023 · After close | +26.9% |
| Q1 2023 | Apr 26, 2023 · After close | +6.4% |
| Q4 2022 | Feb 22, 2023 · After close | −6.8% |
| Q3 2022 | Oct 26, 2022 · After close | +6.5% |
| Q2 2022 | Jul 27, 2022 · After close | −17.7% |
| Q1 2022 | Apr 27, 2022 · After close | −40.1% |
| Q4 2021 | Feb 22, 2022 · After close | −5.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 14 slides | Oct 28, 2026 |
| Investor Presentation (2026) | Investor deck | 52 slides | Oct 19, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 14 slides | Jul 29, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 14 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 13 slides | Feb 25, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference 2026 | Conference | 19 slides | Jan 12, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 13 slides | Oct 29, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 13 slides | Jul 29, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 13 slides | Apr 30, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 14 slides | Feb 26, 2025 |
Show 50 decks
This page holds 50 of 51 decks. Open Decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.57B | 2.60B | 2.41B | 2.03B | 1.09B | 553.3M | 417.9M | 233.3M | 123.2M |
| Cost of revenue | 744.0M | 650.3M | 390.8M | 184.5M | 128.7M | 61.6M | 32.0M | |||
| Gross profit | 1.66B | 1.38B | 703.1M | 368.8M | 289.2M | 171.7M | 91.2M | |||
| Research and development | 277.9M | 307.3M | 348.5M | 333.6M | 311.9M | 164.9M | 64.6M | 54.4M | 34.5M | 21.8M |
| Operating income | -263.0M | -1.02B | -248.6M | -13.7B | -265.6M | -506.4M | -80.4M | -70.9M | -75.4M | -62.7M |
| Depreciation and amortization | 256.0M | 204.2M | 69.5M | 39.0M | 35.6M | 19.1M | 8.27M | |||
| EBITDA | -13.4B | -61.4M | -436.9M | -41.5M | -35.3M | -56.3M | -54.4M | |||
| Interest expense | 19.7M | 23.8M | 22.3M | 21.9M | 81.1M | |||||
| Income before tax | -235.5M | -993.7M | -219.6M | -13.7B | -384.7M | -576.0M | -109.5M | -97.0M | -107.0M | -73.7M |
| Income tax | -35.2M | 7.59M | 760.0K | -3.81M | 44.1M | -90.9M | -10.6M | 118.0K | -225.0K | 510.0K |
| Net income | -200.3M | -1.00B | -220.4M | -13.7B | -428.8M | -485.1M | -98.9M | -97.1M | -106.8M | -74.2M |
| Earnings per share, basic | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 |
| Earnings per share, diluted | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 781.1M | 1.30B | 1.12B | 918.2M | 893.5M | 733.3M | 514.4M | 424.0M | 42.8M | 50.0M |
| Short-term investments | 0 | 2.54M | 53.2M | 2.71M | 54.5M | |||||
| Receivables | 192.8M | 214.1M | 217.4M | 210.6M | 169.0M | 169.3M | 56.9M | 43.6M | 27.1M | 13.8M |
| Inventory | 38.2M | 38.1M | 29.5M | 56.3M | 73.1M | 56.5M | 0 | |||
| Current assets | 1.12B | 1.66B | 1.49B | 1.32B | 1.23B | 1.06B | 588.0M | 532.7M | 156.2M | 82.7M |
| Property, plant and equipment | 27.0M | 29.5M | 32.0M | 29.6M | 27.2M | 28.6M | 10.3M | 10.1M | 8.96M | 7.48M |
| Goodwill | 283.2M | 283.2M | 1.07B | 1.07B | 14.5B | 14.6B | 746.1M | 737.2M | 498.5M | 188.2M |
| Total assets | 2.86B | 3.52B | 4.39B | 4.35B | 17.7B | 17.8B | 1.60B | 1.53B | 824.4M | 303.7M |
| Accounts payable | 48.0M | 33.1M | 43.6M | 47.7M | 47.3M | 46.0M | 9.07M | 7.77M | 3.88M | 2.24M |
| Current liabilities | 404.7M | 941.5M | 420.6M | 399.8M | 331.0M | 332.6M | 90.2M | 62.4M | 40.3M | 21.1M |
| Long-term debt | 42.4M | |||||||||
| Total debt | 0 | 42.6M | 0 | 44.4M | ||||||
| Total liabilities | 1.47B | 2.03B | 2.07B | |||||||
| Shareholders' equity | 1.39B | 1.49B | 2.33B | 2.31B | 16.0B | 15.9B | 1.01B | 1.01B | 558.9M | 230.9M |
| Shares outstanding | 178.3M | 173.4M | 166.7M | 162.8M | 160.5M | 150.3M | 72.8M | 70.5M | 61.5M | 46.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 294.4M | 293.7M | 350.0M | 189.3M | 194.0M | -53.5M | 29.9M | -4.86M | -34.4M | -51.9M |
| Capital spending | -8.89M | -10.8M | -11.5M | -16.5M | -8.53M | -4.02M | -3.51M | -4.01M | -2.63M | -2.11M |
| Free cash flow | 285.5M | 282.9M | 338.6M | 172.8M | 185.5M | -57.5M | 26.4M | -8.87M | -37.1M | -54.0M |
| Cash from investing | -266.0M | -124.1M | -156.3M | -167.7M | -73.0M | -591.0M | 25.0M | -257.5M | -448.4M | 26.1M |
| Cash from financing | -551.7M | 8.31M | 10.9M | 6.50M | 40.9M | 859.1M | 35.1M | 645.6M | 475.4M | 20.7M |
| Change in cash | -523.3M | 177.9M | 204.5M | 28.0M | 162.0M | 214.7M | 90.0M | 383.3M | -7.39M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 6, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Nov 3, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 28, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 8, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Sep 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 1, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 31, 2026 | Management or board change | SEC |
| 8-K · Current report | Aug 13, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 4, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 3, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 29, 2026 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 22, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| SD · Specialized disclosure | May 26, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 8-K · Current report | May 21, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Apr 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 29, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 7, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 7, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 7, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 30, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4/A · Change in ownership, amended | Mar 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Feb 26, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 26, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 19, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 19, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 18, 2026 | Management or board change | SEC |
| 8-K · Current report | Feb 12, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Dec 12, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 12, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 17, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2025 | Results | SEC |
| 8-K · Current report | Oct 23, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jul 23, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jun 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| SD · Specialized disclosure | May 27, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 8-K · Current report | May 23, 2025 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | May 19, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | May 5, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 1, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 30, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 24, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 8, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 8, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 8, 2025 | Meeting notice | SEC |
| 144 · Notice of proposed sale | Apr 7, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 21, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Feb 27, 2025 | Offer document | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2025 | Results | SEC |
This page holds 200 of 1,001 filings. Open Filings
Cap table
Built by 6ix from Teladoc Health, Inc.’s releases · as of Oct 23, 2026
- Common shares
- 182,293,675
- Fully diluted
- 182,293,675
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 182,293,675 | Oct 23, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 23, 2026 | 182,293,675 |
| Jun 30, 2026 | 178,315,400 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Brian P McAndrews Other companies: Frontdoor, Inc. (Director · Since at least Oct 1, 2018); New York Times Company (the) (Director · Since at least May 1, 2013); Chewy, Inc. (Director · Sep 10, 2019 – Jul 16, 2020 · Past); GrubHub Inc (Director · Apr 3, 2014 – Jun 15, 2021 · Past); Pandora Media Inc (President, Chairman and CEO, Director · Sep 11, 2013 – Feb 12, 2016 · Past); Clearwire Corp (Director · Jul 9, 2013 – Jul 9, 2013 · Past); Fisher Communications Inc (Director · May 9, 2013 – Aug 8, 2013 · Past) | Director · Sep 18, 2017 – May 30, 2019 · Past |
| Dana G Mead Jr Other companies: Mobia Medical, Inc. (Director · Since at least May 7, 2026); Pulmonx Corporation (Director · Since at least Sep 30, 2020); Inspire Medical Systems, Inc. (Director · Since at least May 2, 2018); Inari Medical Inc (Director · Oct 1, 2021 – Feb 19, 2025 · Past); Intersect ENT Inc (Director · Jun 2, 2016 – May 13, 2022 · Past) | Director · May 12, 2016 – Aug 8, 2016 · Past |
| Hemant Taneja Other companies: General Catalyst Global Resilience Merger Corp. (Director · Since at least Apr 29, 2026); Samsara Inc. (Director · Dec 14, 2021 – Mar 22, 2024 · Past); Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Health Assurance Acquisition Corp (Chief Executive Officer, Director · Nov 12, 2020 – Nov 12, 2020 · Past); Livongo Health Inc (Director · Jul 24, 2019 – Oct 30, 2020 · Past) | Director · Nov 19, 2020 – Apr 19, 2021 · Past |
| Michael Smith Other companies: Ulta Beauty, Inc. (Director · Since at least Sep 18, 2019); MillerKnoll, Inc. (Member of the Board of Directors · Since at least Jan 16, 2019); Big Sky Growth Partners Inc (Director · Apr 28, 2021 – Apr 28, 2021 · Past); Voya Financial, Inc. (See Remarks · Feb 18, 2021 – Oct 21, 2022 · Past); Stitch Fix, Inc. (Director · Nov 16, 2017 – Dec 15, 2021 · Past) | Director · Since at least Feb 18, 2026 |
| William H Frist Other companies: Select Medical Holdings Corporation (Director · Since at least May 26, 2010); Accolade, Inc. (Director · Jul 1, 2020 – Jun 16, 2021 · Past); Mirion Technologies, Inc. (Director · Jun 29, 2020 – Aug 13, 2020 · Past); Aecom (Director · Oct 17, 2014 – Mar 6, 2020 · Past); URS Corp (Director · Nov 17, 2009 – Oct 17, 2014 · Past) | Director · Jun 30, 2015 – May 26, 2022 · Past |
| Mark V. Anquillare Other companies: Guidewire Software, Inc. (Board Member · Since at least Sep 23, 2024); TruBridge, Inc. (Director · Since at least Mar 15, 2024); Verisk Analytics, Inc. (President · Oct 6, 2009 – Jan 15, 2023 · Past) | Director · Since at least Aug 3, 2026 |
| David L Shedlarz Other companies: Pitney Bowes Inc. (Director · May 9, 2016 – Apr 28, 2023 · Past); The Hershey Company (Director · Apr 1, 2016 – Apr 1, 2021 · Past) | Director · Since at least Sep 19, 2016 |
| Mala Murthy Other companies: TriNet Group, Inc. (Executive Vice President and Chief Financial Officer · Since at least Oct 29, 2025); Avantor, Inc. (Director · Since at least Oct 28, 2021) | CHIEF FINANCIAL OFFICER · Since at least Jun 28, 2019 |
| Mark Hirschhorn Other companies: American Well Corporation (Chief Financial Officer · Since at least Oct 21, 2024); Talkspace, Inc. (President and COO · Jun 22, 2021 – Jul 15, 2021 · Past) | Executive VP, COO and CFO · Oct 2, 2017 – Dec 13, 2018 · Past |
| Christopher Bischoff Other companies: Livongo Health Inc (Director · Jul 24, 2019 – Oct 30, 2020 · Past) | Director · Nov 19, 2020 – May 17, 2022 · Past |
All 40 people
| Person | Seat |
|---|---|
| David William Sides Other companies: Nextgen Healthcare Inc (President and CEO, Director · Sep 22, 2021 – Nov 9, 2023 · Past) | Chief Operating Officer · Aug 1, 2019 – Jul 29, 2021 · Past |
| Jason Eric Evans Other companies: Surgery Partners, Inc. (Chief Executive Officer · Since at least Feb 24, 2021) | Director · Since at least Sep 20, 2023 |
| Richard J Napolitano Other companies: MSCI Inc. (Principal Accounting Officer · Feb 10, 2014 – May 7, 2018 · Past) | CHIEF ACCOUNTING OFFICER · Jan 28, 2021 – Mar 19, 2024 · Past |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY · Since at least Jun 1, 2022 |
| Alan Roga | Chief Clinical Officer · Sep 15, 2025 – Nov 4, 2026 · Past |
| Arnnon Geshuri | CHIEF PEOPLE OFFICER · Oct 30, 2020 – Aug 30, 2024 · Past |
| Carlos Nueno | President, Global Health Systems · Since at least Sep 25, 2024 |
| Catherine Jacobson | Director · Since at least Mar 3, 2020 |
| Charles Divita III | CHIEF EXECUTIVE OFFICER, Director · Since at least Jun 10, 2024 |
| Chuck Divita | Chief Executive Officer · Since at least Sep 14, 2026 |
| Claus Torp Jensen | CHIEF INNOVATION OFFICER · Dec 1, 2023 – Dec 1, 2023 · Past |
| Daniel Trencher | CHIEF STRATEGY OFFICER · Oct 30, 2020 – Aug 30, 2024 · Past |
| Dave Ross | Chief Technology Officer · Since at least Nov 6, 2025 |
| David B Snow Jr | Director · Since at least May 14, 2021 |
| Ethan Berke | Chief Medical Officer · Since at least Jul 23, 2026 |
| Fernando Madeira | President, BetterHelp · Since at least Apr 30, 2025 |
| Fernando M Rodrigues | President of BetterHelp · Since at least Sep 25, 2024 |
| James L Cave | INTERIM CAO · May 4, 2024 – Aug 30, 2024 · Past |
| Jonathan Dorfman | Chief Legal Officer · Since at least Sep 25, 2026 |
| Joseph Ronald Catapano | Chief Accounting Officer · Since at least Apr 1, 2026 |
| Kelly Bliss | President, U.S. Group Health · Since at least Jul 23, 2026 |
| Laura Whipple | Chief Communications & Brand Officer · Since at least Nov 5, 2026 |
| Michael Grasher | Chief Financial Officer · Since at least Aug 31, 2026 |
| Michael H King | Chief Sales Officer · Jun 30, 2015 – May 25, 2017 · Past |
| Michael Willem Waters | CHIEF OPERATING OFFICER · Jul 25, 2022 – Aug 30, 2024 · Past |
| Peter N Nieves | EVP and CRO · Mar 13, 2017 – Mar 13, 2017 · Past |
| Susan Salka | Director · Since at least Mar 30, 2026 |
| Teri Condon | Chief of Staff to the CEO · Since at least Nov 5, 2026 |
| Tom Mawhinney | Director · Jun 30, 2015 – May 25, 2018 · Past |
| Tom Stephenson | Chief Revenue Officer · Aug 28, 2025 – Nov 4, 2026 · Past |
Log in to ask 6ix AI your own questions about Teladoc Health, Inc.